These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 2116173)

  • 1. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Koga T; Shimada Y; Kuroda M; Tsujita Y; Hasegawa K; Yamazaki M
    Biochim Biophys Acta; 1990 Jul; 1045(2):115-20. PubMed ID: 2116173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens.
    Mosley ST; Kalinowski SS; Schafer BL; Tanaka RD
    J Lipid Res; 1989 Sep; 30(9):1411-20. PubMed ID: 2513368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of cholesterol synthesis in liver versus extrahepatic tissues by HMG-CoA reductase inhibitors.
    Parker RA; Clark RW; Sit SY; Lanier TL; Grosso RA; Wright JJ
    J Lipid Res; 1990 Jul; 31(7):1271-82. PubMed ID: 2401858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cholesterol synthesis ex vivo and in vivo by fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Yamamoto A; Itoh S; Hoshi K; Ichihara K
    Experientia; 1995 Mar; 51(3):223-6. PubMed ID: 7698284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term administration of HMG-CoA reductase inhibitors on cholesterol synthesis in lens.
    Kalinowski SS; Tanaka RD; Mosley ST
    Exp Eye Res; 1991 Aug; 53(2):179-86. PubMed ID: 1915674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-selective inhibition of sterol synthesis in mice by pravastatin sodium after a single or repeated oral administrations.
    Koga T; Kikuchi T; Miyazaki A; Koike H
    Lipids; 1995 Aug; 30(8):775-9. PubMed ID: 7475995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue selectivity of pravastatin sodium, lovastatin and simvastatin. The relationship between inhibition of de novo sterol synthesis and active drug concentrations in the liver, spleen and testis in rat.
    Koga T; Fukuda K; Shimada Y; Fukami M; Koike H; Tsujita Y
    Eur J Biochem; 1992 Oct; 209(1):315-9. PubMed ID: 1396707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes.
    Masters BA; Palmoski MJ; Flint OP; Gregg RE; Wang-Iverson D; Durham SK
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):163-74. PubMed ID: 7878672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of rat brain prostaglandin D synthase by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Islam F; Watanabe Y; Hayaishi O
    Biochem Int; 1990 Nov; 22(4):601-5. PubMed ID: 2127671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo.
    Germershausen JI; Hunt VM; Bostedor RG; Bailey PJ; Karkas JD; Alberts AW
    Biochem Biophys Res Commun; 1989 Feb; 158(3):667-75. PubMed ID: 2493245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercholesterolaemia: simvastatin and pravastatin alter cholesterol metabolism by different mechanisms.
    Owens D; Collins P; Johnson A; Tighe O; Robinson K; Tomkin GH
    Biochim Biophys Acta; 1991 Apr; 1082(3):303-9. PubMed ID: 1903069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol content of the rat lens is lowered by administration of simvastatin, but not by pravastatin.
    De Vries AC; Vermeer MA; Bredman JJ; Bär PR; Cohen LH
    Exp Eye Res; 1993 Apr; 56(4):393-9. PubMed ID: 8500554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cholesterol synthesis and hepatic 3-hydroxy-3-methylglutaryl--CoA reductase in rats by simvastatin and pravastatin.
    Del Puppo M; Rauli S; Galli Kienle M
    Lipids; 1995 Nov; 30(11):1057-61. PubMed ID: 8569435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
    Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
    Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pravastatin and simvastatin differently inhibit cholesterol biosynthesis in human lens.
    de Vries AC; Vermeer MA; Bloemendal H; Cohen LH
    Invest Ophthalmol Vis Sci; 1993 Feb; 34(2):377-84. PubMed ID: 8440592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Aoki T; Nishimura H; Nakagawa S; Kojima J; Suzuki H; Tamaki T; Wada Y; Yokoo N; Sato F; Kimata H; Kitahara M; Toyoda K; Sakashita M; Saito Y
    Arzneimittelforschung; 1997 Aug; 47(8):904-9. PubMed ID: 9296275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
    Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
    N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin.
    Serajuddin AT; Ranadive SA; Mahoney EM
    J Pharm Sci; 1991 Sep; 80(9):830-4. PubMed ID: 1800703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology and mechanism of action of the new HMG-CoA reductase inhibitors.
    Sirtori CR
    Pharmacol Res; 1990; 22(5):555-63. PubMed ID: 2126139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytes.
    Corsini A; Raiteri M; Soma M; Fumagalli R; Paoletti R
    Pharmacol Res; 1991 Feb; 23(2):173-80. PubMed ID: 1905808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.